3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid

Details

Top
Internal ID 68b74ee9-5d0e-4a0a-8d68-ce49a06193bb
Taxonomy Organic oxygen compounds > Organooxygen compounds > Alcohols and polyols > Cyclitols and derivatives > Shikimic acids and derivatves
IUPAC Name 3,4,5-trihydroxycyclohexene-1-carboxylic acid
SMILES (Canonical) C1C(C(C(C=C1C(=O)O)O)O)O
SMILES (Isomeric) C1C(C(C(C=C1C(=O)O)O)O)O
InChI InChI=1S/C7H10O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,4-6,8-10H,2H2,(H,11,12)
InChI Key JXOHGGNKMLTUBP-UHFFFAOYSA-N
Popularity 26 references in papers

Physical and Chemical Properties

Top
Molecular Formula C7H10O5
Molecular Weight 174.15 g/mol
Exact Mass 174.05282342 g/mol
Topological Polar Surface Area (TPSA) 98.00 Ų
XlogP -1.70
Atomic LogP (AlogP) -1.52
H-Bond Acceptor 4
H-Bond Donor 4
Rotatable Bonds 1

Synonyms

Top
3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid
2306-23-2
Skikimic acid
3,4,5-Trihydroxycyclohex-1-enecarboxylic acid
3,4,5-trihydroxycyclohexene-1-carboxylic acid
ShikimicAcid
Bracken fern toxic component
1-cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-
1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, [3R-(3.alpha.,4.alpha.,5.beta.)]-
MFCD00066278
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7866 78.66%
Caco-2 - 0.9343 93.43%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability + 0.6429 64.29%
Subcellular localzation Mitochondria 0.7120 71.20%
OATP2B1 inhibitior - 0.8550 85.50%
OATP1B1 inhibitior + 0.9507 95.07%
OATP1B3 inhibitior + 0.9571 95.71%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.9588 95.88%
BSEP inhibitior - 0.9860 98.60%
P-glycoprotein inhibitior - 0.9837 98.37%
P-glycoprotein substrate - 0.9760 97.60%
CYP3A4 substrate - 0.7137 71.37%
CYP2C9 substrate - 0.7723 77.23%
CYP2D6 substrate - 0.8802 88.02%
CYP3A4 inhibition - 0.9563 95.63%
CYP2C9 inhibition - 0.9372 93.72%
CYP2C19 inhibition - 0.9487 94.87%
CYP2D6 inhibition - 0.9366 93.66%
CYP1A2 inhibition - 0.9499 94.99%
CYP2C8 inhibition - 0.9810 98.10%
CYP inhibitory promiscuity - 0.9662 96.62%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9100 91.00%
Carcinogenicity (trinary) Non-required 0.6723 67.23%
Eye corrosion - 0.9714 97.14%
Eye irritation + 0.7389 73.89%
Skin irritation + 0.5051 50.51%
Skin corrosion - 0.9010 90.10%
Ames mutagenesis - 0.9300 93.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7895 78.95%
Micronuclear + 0.5659 56.59%
Hepatotoxicity + 0.5375 53.75%
skin sensitisation + 0.4766 47.66%
Respiratory toxicity - 0.5556 55.56%
Reproductive toxicity + 0.5889 58.89%
Mitochondrial toxicity - 0.6125 61.25%
Nephrotoxicity + 0.4628 46.28%
Acute Oral Toxicity (c) IV 0.4690 46.90%
Estrogen receptor binding - 0.8876 88.76%
Androgen receptor binding - 0.7785 77.85%
Thyroid receptor binding - 0.8108 81.08%
Glucocorticoid receptor binding - 0.8006 80.06%
Aromatase binding - 0.8835 88.35%
PPAR gamma - 0.8418 84.18%
Honey bee toxicity - 0.9141 91.41%
Biodegradation + 0.6000 60.00%
Crustacea aquatic toxicity - 0.7900 79.00%
Fish aquatic toxicity + 0.7319 73.19%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.81% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.91% 91.11%
CHEMBL4040 P28482 MAP kinase ERK2 84.32% 83.82%
CHEMBL2581 P07339 Cathepsin D 82.72% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 81.98% 95.56%
CHEMBL1811 P34995 Prostanoid EP1 receptor 81.22% 95.71%

Cross-Links

Top
PubChem 1094
NPASS NPC275255
LOTUS LTS0197942
wikiData Q104402824